Clinical Trials Browser

Observational × Neuroectodermal Tumors, Primitive, Peripheral × Clear all

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

NCT04300179 2020-12-17

Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt

Completed

59 enrolled

Sarcoma

Bone Neoplasms, Neoplasms, Sarcoma, Ewing, Soft Tissue Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT02159443 2020-11-05

Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody

Completed

76 enrolled

CNSDermatologicSarcoma

Melanoma, Neuroblastoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT01876303 2016-07-14

Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma

Completed

1,650 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

NCT01365949 2016-07-11

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

Completed

40 enrolled

Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00898053 2016-05-17

Study of Tumor Samples From Patients With Ewing Sarcoma

Completed

200 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

NCT00003793 2014-08-05

Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

Completed

294 enrolled

MyeloidOther hematologic neoplasmSarcoma

Fibrosarcoma, Leukemia, Myelodysplastic Syndromes, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00514345 2013-08-12

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Unknown

300 enrolled

Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00048984 2013-06-24

Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma

Completed

637 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

Clinical Trials

MGMTLiberati

Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt

Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody

Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

Study of Tumor Samples From Patients With Ewing Sarcoma

Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma